Truist Lifts UnitedHealth (UNH) Price Target on Strong Star Ratings Outlook

UnitedHealth Group Incorporated (NYSE:UNH) ranks among the hot stocks to invest in right now. Truist Securities reaffirmed its Buy rating on UnitedHealth Group Incorporated (NYSE:UNH) and boosted its price target from $310 to $365 on September 9. The hike follows UnitedHealth’s release of an 8-K filing with preliminary 2026 Star ratings data.

According to the filing, the company expects around 78% of its membership to be in 4+ Star plans for Payment Year 2027, which aligns with management’s projections and past patterns.

Additionally, UnitedHealth Group Incorporated (NYSE:UNH) reiterated its goal of at least $16 in adjusted earnings per share for the fiscal year 2025, which includes the recently concluded acquisition of Amedisys. The company stated that the acquisition is likely to dilute adjusted EPS slightly due to finance expenses and integration-related investments.

UnitedHealth Group Incorporated (NYSE:UNH) is a renowned US multinational corporation that provides managed healthcare and insurance services. The company operates through four main segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx.

While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 Best Magic Formula Stocks for 2025 and 10 Best Retirement Stocks to Buy According to Hedge Funds.

Disclosure: None. This article is originally published at Insider Monkey.